{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:52:42Z","timestamp":1791856362997,"version":"4.3.4"},"reference-count":70,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T00:00:00Z","timestamp":1653955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>Rift Valley fever (RVF) is a viral disease caused by a member of the Bunyavirales family causing severe infections in humans. The RVF virus is an enveloped, negative-sense, single-stranded RNA virus that can infect both animals and humans. The symptoms associated with these infections span from minor (fever and headaches) to severe (meningoencephalitis and hemorrhagic fever syndrome) symptoms. Despite the outbreaks of the RVF virus being reported in different parts of the world, no effective therapy is available. Herein, the development of an efficient vaccine is critical for the control of infections associated with the RVF virus. Moreover, computational vaccine approaches are helpful in the design of specific, safe, and stable peptide-based designs when compared to the conventional methods of vaccine development. In this study, the whole proteome of the virus, comprising four proteins (NP, L, GP, and NSP), was screened to find putative vaccine epitope sequences (T cell, B cell, and HTL) specific for each protein. These shortlisted epitopes were then combined with flexible linkers to design protein-specific and proteome-wide immunogenic multi-epitope-based vaccine constructs. The results revealed that these multi-epitope vaccine constructs (MEVCs) are strongly antigenic and non-allergenic in nature. The efficacy of these constructs was further validated by docking with immune receptors, which revealed strong binding interactions with human TLR8. Using the MD simulation approach, the binding stability and residual flexibility of the best vaccine construct (proteome-wide) were confirmed, which revealed stable dynamic and favorable features. Furthermore, <jats:italic>in-silico<\/jats:italic> cloning and immune simulation analysis confirmed the expression and production of immune factors, that is, IgM, IgG, and IL-6, against the proposed vaccine designs. Additionally, 3D models of all the MEVC constructs have been developed and evaluated for potential immunization against the RVF virus. Finally, the proteome-wide vaccine candidate (MEVC-PW-RVFV) with the highest immune reinforcement potential provides new insights into the development of future vaccines against the emerging RVF virus.<\/jats:p>","DOI":"10.3389\/fmicb.2022.921683","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T08:23:27Z","timestamp":1653985407000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Proteome-Wide and Protein-Specific Multi-Epitope Vaccine Constructs Against the Rift Valley Fever Virus Outbreak Using Integrated Omics Approaches"],"prefix":"10.3389","volume":"13","author":[{"given":"Aqel","family":"Albutti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/2020.03.18.997197","article-title":"Development of multi-epitope subunit vaccine for protection against the norovirus' infections based on computational vaccinology","volume":"40","author":"Ahmad","year":"2020","journal-title":"J. Biomol. Struct. Dyn"},{"key":"B2","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3390\/vaccines9030293","article-title":"Immuno-informatics analysis of Pakistan-based HCV Subtype-3a for chimeric polypeptide vaccine design","volume":"9","author":"Ahmad","year":"2021","journal-title":"Vaccines"},{"key":"B3","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/s41598-018-37070-z","article-title":"Immunoinformatic and systems biology approaches to predict and validate peptide vaccines against Epstein\u2013Barr virus (EBV)","volume":"9","author":"Ali","year":"2019","journal-title":"Sci. Rep"},{"key":"B4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1177\/0300985809354350","article-title":"Agricultural diseases on the move early in the third millennium","volume":"47","author":"Arzt","year":"2010","journal-title":"Vet. Pathol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"997","DOI":"10.3390\/biology10100997","article-title":"Designing a Multi-Epitope Vaccine against Chlamydia trachomatis by employing integrated core proteomics, immuno-informatics and in silico approaches","volume":"10","author":"Aslam","year":"2021","journal-title":"Biology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1586\/erv.09.160","article-title":"Advances in the design and delivery of peptide subunit vaccines with a focus on toll-like receptor agonists","volume":"9","author":"Black","year":"2010","journal-title":"Exp. Rev. Vaccines"},{"key":"B7","doi-asserted-by":"publisher","first-page":"6098","DOI":"10.1128\/JVI.02641-10","article-title":"Rift valley fever: recent insights into pathogenesis and prevention","volume":"85","author":"Boshra","year":"2011","journal-title":"J. Virol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/1471-2105-7-153","article-title":"Predicting population coverage of T-cell epitope-based diagnostics and vaccines","volume":"7","author":"Bui","year":"2006","journal-title":"BMC Bioinformatics"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1002\/jcc.20290","article-title":"The Amber biomolecular simulation programs","volume":"26","author":"Case","year":"2005","journal-title":"J. Comput. Chem"},{"key":"B10","doi-asserted-by":"publisher","first-page":"842329","DOI":"10.1155\/2012\/842329","article-title":"How the interval between prime and boost injection affects the immune response in a computational model of the immune system","volume":"2012","author":"Castiglione","year":"2012","journal-title":"Comput. Math. Methods Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"D506","DOI":"10.1093\/nar\/gky1049","article-title":"UniProt: a worldwide hub of protein knowledge","volume":"47","author":"Consortium","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"640","DOI":"10.3389\/fimmu.2017.00640","article-title":"An approach for a synthetic ctl vaccine design against zika flavivirus using class i and class ii epitopes identified by computer modeling","volume":"8","author":"Cunha-Neto","year":"2017","journal-title":"Front. Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1016\/j.vaccine.2009.12.062","article-title":"Rift Valley fever virus subunit vaccines confer complete protection against a lethal virus challenge","volume":"28","author":"De Boer","year":"2010","journal-title":"Vaccine"},{"key":"B14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1745-6150-8-30","article-title":"Designing of interferon-gamma inducing MHC class-II binders","volume":"8","author":"Dhanda","year":"2013","journal-title":"Biol. Direct"},{"key":"B15","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-2105-8-4","article-title":"VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines","volume":"8","author":"Doytchinova","year":"2007","journal-title":"BMC Bioinformatics"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.3390\/pathogens10101334","article-title":"Distribution and molecular identification of culex pipiens and culex tritaeniorhynchus as potential vectors of Rift Valley fever virus in Jazan, Saudi Arabia","volume":"10","author":"Eifan","year":"2021","journal-title":"Pathogens"},{"key":"B17","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/jmr.893","article-title":"Predicting linear B-cell epitopes using string kernels","volume":"21","author":"EL-Manzalawy","year":"2008","journal-title":"J. Mol. Recognit"},{"key":"B18","doi-asserted-by":"publisher","first-page":"105151","DOI":"10.1016\/j.compbiomed.2021.105151","article-title":"Designing of a multi-epitopes-based peptide vaccine against rift valley fever virus and its validation through integrated computational approaches","volume":"141","author":"Fatima","year":"2021","journal-title":"Comput. Biol. Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3201\/eid0402.980218","article-title":"New vectors of Rift Valley fever in west Africa","volume":"4","author":"Fontenille","year":"1998","journal-title":"Emerging Infect. Dis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"613","DOI":"10.20506\/rst.23.2.1500","article-title":"Rift Valley fever","volume":"23","author":"Gerdes","year":"2004","journal-title":"Rev. Sci. Tech"},{"key":"B21","doi-asserted-by":"publisher","first-page":"W526","DOI":"10.1093\/nar\/gki376","article-title":"JCat: a novel tool to adapt codon usage of a target gene to its potential expression host","volume":"33","author":"Grote","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1099\/vir.0.2008\/002097-0","article-title":"T7 RNA polymerase-dependent and-independent systems for cDNA-based rescue of Rift Valley fever virus","volume":"89","author":"Habjan","year":"2008","journal-title":"J. Gen. Virol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1080\/07391102.2019.1647286","article-title":"Contriving a chimeric polyvalent vaccine to prevent infections caused by herpes simplex virus (type-1 and type-2): an exploratory immunoinformatic approach","volume":"38","author":"Hasan","year":"2020","journal-title":"J. Biomol. Struct. Dyn"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e0003584","DOI":"10.1371\/journal.pntd.0003584","article-title":"Association of symptoms and severity of rift valley fever with genetic polymorphisms in human innate immune pathways","volume":"9","author":"Hise","year":"2015","journal-title":"PLoS Negl. Trop. Dis"},{"key":"B25","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3390\/v3050493","article-title":"The pathogenesis of Rift Valley fever","volume":"3","author":"Ikegami","year":"2011","journal-title":"Viruses"},{"key":"B26","doi-asserted-by":"publisher","first-page":"104705","DOI":"10.1016\/j.compbiomed.2021.104705","article-title":"Pan-vaccinomics approach towards a universal vaccine candidate against WHO priority pathogens to address growing global antibiotic resistance","volume":"136","author":"Ismail","year":"2021","journal-title":"Comput. Biol. Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"4117","DOI":"10.1021\/acs.jmedchem.9b02128","article-title":"Rationally designed small-molecule inhibitors targeting an unconventional pocket on the TLR8 Protein\u2013Protein interface","volume":"63","author":"Jiang","year":"2020","journal-title":"J. Med. Chem"},{"key":"B28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.actatropica.2018.01.015","article-title":"Rift Valley Fever in Egypt and other African countries: historical review, recent outbreaks and possibility of disease occurrence in Egypt","volume":"181","author":"Kenawy","year":"2018","journal-title":"Acta Trop"},{"key":"B29","doi-asserted-by":"publisher","first-page":"104420","DOI":"10.1016\/j.compbiomed.2021.104420","article-title":"Immunogenomics guided design of immunomodulatory Multi-Epitope Subunit Vaccine against the SARS-CoV-2 new variants, and its validation through in silico cloning and immune simulation","volume":"133","author":"Khan","year":"","journal-title":"Comput. Biol. Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"112176","DOI":"10.1016\/j.biopha.2021.112176","article-title":"SARS-CoV-2 new variants: characteristic features and impact on the efficacy of different vaccines","volume":"143","author":"Khan","year":"","journal-title":"Biomed. Pharmacother"},{"key":"B31","doi-asserted-by":"publisher","first-page":"13321","DOI":"10.1038\/s41598-019-49354-z","article-title":"Immunoinformatics approaches to explore Helicobacter Pylori proteome (Virulence Factors) to design B and T cell multi-epitope subunit vaccine","volume":"9","author":"Khan","year":"","journal-title":"Sci. Rep"},{"key":"B32","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.meegid.2019.06.006","article-title":"Immunoinformatics and structural vaccinology driven prediction of multi-epitope vaccine against Mayaro virus and validation through in-silico expression","volume":"73","author":"Khan","year":"","journal-title":"Infect. Genet. Evol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.3390\/molecules27072375","article-title":"Potential immunogenic activity of computationally designed mRNA-and Peptide-based prophylactic vaccines against MERS, SARS-CoV, and SARS-CoV-2: a reverse vaccinology approach","volume":"27","author":"Khan","year":"","journal-title":"Molecules"},{"key":"B34","doi-asserted-by":"publisher","first-page":"105462","DOI":"10.1016\/j.compbiomed.2022.105462","article-title":"Subtractive proteomics assisted therapeutic targets mining and designing ensemble vaccine against Candida auris for immune response induction","volume":"145","author":"Khan","year":"","journal-title":"Comput. Biol. Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"12622","DOI":"10.1128\/JVI.00841-11","article-title":"Creation of a nonspreading Rift Valley fever virus","volume":"85","author":"Kortekaas","year":"2011","journal-title":"J. Virol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.022","article-title":"Inference of macromolecular assemblies from crystalline state","volume":"372","author":"Krissinel","year":"2007","journal-title":"J. Mol. Biol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1743-422X-6-6","article-title":"Characterisation of immune responses and protective efficacy in mice after immunisation with Rift Valley Fever virus cDNA constructs","volume":"6","author":"Lagerqvist","year":"2009","journal-title":"Virol. J"},{"key":"B38","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1186\/1471-2105-8-424","article-title":"Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction","volume":"8","author":"Larsen","year":"2007","journal-title":"BMC Bioinformatics"},{"key":"B39","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1145\/1810085.1810099","article-title":"Fast and accurate NCBI BLASTP: acceleration with multiphase FPGA-based prefiltering","author":"Mahram","year":"2010","journal-title":"Proceedings of the Proceedings of the 24th ACM International Conference on Supercomputing"},{"key":"B40","doi-asserted-by":"publisher","first-page":"3210","DOI":"10.1021\/acs.chemrev.9b00472","article-title":"Peptide-based vaccines: current progress and future challenges","volume":"120","author":"Malonis","year":"2019","journal-title":"Chem. Rev"},{"key":"B41","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.jviromet.2010.07.015","article-title":"Novel suspension cell-based vaccine production systems for Rift Valley fever virus-like particles","volume":"169","author":"Mandell","year":"2010","journal-title":"J. Virol. Methods"},{"key":"B42","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.virol.2011.09.023","article-title":"Rift Valley fever virus inhibits a pro-inflammatory response in experimentally infected human monocyte derived macrophages and a pro-inflammatory cytokine response may be associated with patient survival during natural infection","volume":"422","author":"McElroy","year":"2012","journal-title":"Virology"},{"key":"B43","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.antiviral.2018.05.009","article-title":"Rift Valley fever in animals and humans: current perspectives","volume":"156","author":"McMillen","year":"2018","journal-title":"Antiviral Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.vaccine.2012.10.118","article-title":"Safety and immunogenicity of recombinant Rift Valley fever MP-12 vaccine candidates in sheep","volume":"31","author":"Morrill","year":"2013","journal-title":"Vaccine"},{"key":"B45","doi-asserted-by":"publisher","first-page":"716735","DOI":"10.3389\/fmolb.2021.716735","article-title":"Discovery of novel inhibitors from medicinal plants for V-Domain Ig Suppressor of T-Cell Activation (VISTA)","volume":"8","author":"Muneer","year":"2021","journal-title":"Front. Mol. Biosci"},{"key":"B46","doi-asserted-by":"publisher","first-page":"28024","DOI":"10.3402\/iee.v5.28024","article-title":"A systematic review of Rift Valley Fever epidemiology 1931\u20132014","volume":"5","author":"Nanyingi","year":"2015","journal-title":"Infect. Ecol. Epidemiol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"105120","DOI":"10.1016\/j.meegid.2021.105120","article-title":"Identification of immunodominant epitopes in allelic variants VK210 and VK247 of Plasmodium Vivax Circumsporozoite immunogen","volume":"96","author":"Naz","year":"2021","journal-title":"Infect. Genet. Evol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.molimm.2019.09.018","article-title":"Designing a multi-epitope vaccine for cross-protection against Shigella spp: an immunoinformatics and structural vaccinology study","volume":"116","author":"Nosrati","year":"2019","journal-title":"Mol. Immunol"},{"key":"B49","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/978-1-4939-6740-7_16","article-title":"\u201cBioinformatics tools and resources for analyzing protein structures,\u201d","volume-title":"Proteome Bioinformatics","author":"Paxman","year":"2017"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0010-4655(95)00041-D","article-title":"AMBER, a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules","volume":"91","author":"Pearlman","year":"1995","journal-title":"Comput. Phys. Commun"},{"key":"B51","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0264-410X(99)00218-2","article-title":"Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience","volume":"18","author":"Pittman","year":"1999","journal-title":"Vaccine"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1128\/CVI.00290-09","article-title":"Vaccines: the fourth century","volume":"16","author":"Plotkin","year":"2009","journal-title":"Clin. Vaccine Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"e9862","DOI":"10.1371\/journal.pone.0009862","article-title":"Computational immunology meets bioinformatics: the use of prediction tools for molecular binding in the simulation of the immune system","volume":"5","author":"Rapin","year":"2010","journal-title":"PLoS ONE"},{"key":"B54","doi-asserted-by":"publisher","first-page":"658","DOI":"10.3390\/vaccines9060658","article-title":"Integrated core proteomics, subtractive proteomics, and immunoinformatics investigation to unveil a potential Multi-Epitope Vaccine against Schistosomiasis","volume":"9","author":"Rehman","year":"2021","journal-title":"Vaccines"},{"key":"B55","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1021\/ct400341p","article-title":"PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data","volume":"9","author":"Roe","year":"2013","journal-title":"J. Chem. Theory Comput"},{"key":"B56","doi-asserted-by":"publisher","first-page":"bbaa294","DOI":"10.1093\/bib\/bbaa294","article-title":"AlgPred 2.0: an improved method for predicting allergenic proteins and mapping of IgE epitopes","volume":"22","author":"Sharma","year":"2021","journal-title":"Brief. Bioinform"},{"key":"B57","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-1-62703-646-7_6","article-title":"\u201cClustal Omega, accurate alignment of very large numbers of sequences,\u201d","volume-title":"Multiple Sequence Alignment Methods","author":"Sievers","year":"2014"},{"key":"B58","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13062-015-0103-4","article-title":"PEPstrMOD: structure prediction of peptides containing natural, non-natural and modified residues","volume":"10","author":"Singh","year":"2015","journal-title":"Biol. Direct"},{"key":"B59","first-page":"35","article-title":"Rift Valley fever: transmission of the virus by mosquitoes","volume":"30","author":"Smithburn","year":"1949","journal-title":"Br. J. Exp. Pathol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"136","DOI":"10.4269\/ajtmh.1996.54.136","article-title":"Vector competence of Egyptian mosquitoes for Rift Valley fever virus","volume":"54","author":"Turell","year":"1996","journal-title":"Am. J. Trop. Med. Hyg"},{"key":"B61","doi-asserted-by":"publisher","first-page":"104389","DOI":"10.1016\/j.compbiomed.2021.104389","article-title":"Designing multi-epitope vaccine against Staphylococcus aureus by employing subtractive proteomics, reverse vaccinology and immuno-informatics approaches","volume":"132","author":"Ul Qamar","year":"","journal-title":"Comput. Biol. Med"},{"key":"B62","doi-asserted-by":"publisher","first-page":"104929","DOI":"10.1016\/j.compbiomed.2021.104929","article-title":"Structural probing of HapR to identify potent phytochemicals to control Vibrio cholera through integrated computational approaches","volume":"138","author":"Ul Qamar","year":"","journal-title":"Comput. Biol. Med"},{"key":"B63","doi-asserted-by":"publisher","first-page":"669812","DOI":"10.3389\/fimmu.2021.669812","article-title":"Development of a novel Multi-Epitope Vaccine against Crimean-Congo Hemorrhagic Fever Virus: an integrated reverse vaccinology, vaccine informatics and biophysics approach","volume":"12","author":"Ul Qamar","year":"","journal-title":"Front. Immunol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"10961","DOI":"10.3390\/ijerph182010961","article-title":"Towards a novel Multi-Epitopes Chimeric Vaccine for simulating strong immune responses and protection against Morganella morganii","volume":"18","author":"Ullah","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"B65","first-page":"867","article-title":"Rift valley fever affecting humans in South Africa-a clinicopathological study","volume":"51","author":"Van Velden","year":"1977","journal-title":"South Afr. Med. J"},{"key":"B66","doi-asserted-by":"publisher","first-page":"D339","DOI":"10.1093\/nar\/gky1006","article-title":"The immune epitope database (IEDB):2018 update","volume":"47","author":"Vita","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.4049\/jimmunol.1001240","article-title":"A genome-wide profiling of the humoral immune response to Chlamydia trachomatis infection reveals vaccine candidate antigens expressed in humans","volume":"185","author":"Wang","year":"2010","journal-title":"J. Immunol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"20617","DOI":"10.1038\/srep20617","article-title":"Chimpanzee adenovirus vaccine provides multispecies protection against Rift Valley fever","volume":"6","author":"Warimwe","year":"2016","journal-title":"Sci. Rep"},{"key":"B69","doi-asserted-by":"publisher","first-page":"W322","DOI":"10.1093\/nar\/gkz397","article-title":"HawkDock: a web server to predict and analyze the protein\u2013protein complex based on computational docking and MM\/GBSA","volume":"47","author":"Weng","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B70","doi-asserted-by":"publisher","first-page":"W365","DOI":"10.1093\/nar\/gkx407","article-title":"HDOCK: a web server for protein\u2013protein and protein\u2013DNA\/RNA docking based on a hybrid strategy","volume":"45","author":"Yan","year":"2017","journal-title":"Nucleic Acids Res"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2022.921683\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T08:23:36Z","timestamp":1653985416000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2022.921683\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,31]]},"references-count":70,"alternative-id":["10.3389\/fmicb.2022.921683"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2022.921683","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,31]]},"article-number":"921683"}}